LD-2 disclosure · 2nd Quarter - Report

VERTEX PHARMACEUTICALS INCORPORATED

2nd Quarter (Apr 1 - June 30) · 2022Posted Jul 19, 2022Filing document ↗LDA record ↗

Expenses$520Kself-filed spend

Client

5 issues

Health Issues
Issues related to FDA regulatory pathways for pharmaceuticals; Issues related to pharmaceutical pricing, health care cost and price transparency: H.R. 3 - "Elijah E. Cummings Lower Drug Costs Now Act"; H.R. 19 - "Lower Costs, More Cures Act"; S. 2164 - "Lower Costs, More Cures Act."; Issues related to health care and prescription drug pricing in H.R. 5376 - "Build Back Better Act"; H.R. 5801 - HELP Copays Act. HR 7506 - "New Era of Preventing End-Stage Kidney Disease Act." S. Res 683 and H.R. 1176 - Recognizing World Sickle Cell Awareness Day.
LobbyistsSAMANTHA VENTIMIGLIA · SCOTT BARNES · MATTHEW O SCHUMAKER · KWAMME ANDERSON
TargetedSENATE · HOUSE OF REPRESENTATIVES
Medicare/Medicaid
Issues related to rare disease and orphan disease patient access in Medicaid (no specific bills).
LobbyistsSAMANTHA VENTIMIGLIA · SCOTT BARNES · MATTHEW O SCHUMAKER · KWAMME ANDERSON
TargetedSENATE · HOUSE OF REPRESENTATIVES
Taxation/Internal Revenue Code
Issues related to corporate and international tax policy and research and development tax credits; Issues related to the Orphan Drug Tax Credit; Issues related to corporate and international tax policy in H.R. 5376 - "Build Back Better Act."

LD-2 disclosure · 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) · 2022Posted Jul 19, 2022Filing document ↗LDA record ↗

Expenses$520Kself-filed spend

5 issues

Health Issues
Issues related to FDA regulatory pathways for pharmaceuticals; Issues related to pharmaceutical pricing, health care cost and price transparency: H.R. 3 - "Elijah E. Cummings Lower Drug Costs Now Act"; H.R. 19 - "Lower Costs, More Cures Act"; S. 2164 - "Lower Costs, More Cures Act."; Issues related to health care and prescription drug pricing in H.R. 5376 - "Build Back Better Act"; H.R. 5801 - HELP Copays Act. HR 7506 - "New Era of Preventing End-Stage Kidney Disease Act." S. Res 683 and H.R. 1176 - Recognizing World Sickle Cell Awareness Day.
LobbyistsSAMANTHA VENTIMIGLIA · SCOTT BARNES · MATTHEW O SCHUMAKER · KWAMME ANDERSON
TargetedSENATE · HOUSE OF REPRESENTATIVES
Medicare/Medicaid
Issues related to rare disease and orphan disease patient access in Medicaid (no specific bills).
LobbyistsSAMANTHA VENTIMIGLIA · SCOTT BARNES · MATTHEW O SCHUMAKER · KWAMME ANDERSON
TargetedSENATE · HOUSE OF REPRESENTATIVES
Taxation/Internal Revenue Code
Issues related to corporate and international tax policy and research and development tax credits; Issues related to the Orphan Drug Tax Credit; Issues related to corporate and international tax policy in H.R. 5376 - "Build Back Better Act."